MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-23-2026
Integer Holdings Corporation Operating Income 2011-2026 | ITGR
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 M | 208 M | 163 M | 113 M | 136 M | 121 M | 158 M | 156 M | 126 M | 92.9 M | 75.7 M | 61.3 M | - | 25.8 M | 61.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 221 M | 25.8 M | 123 M |
Quarterly Operating Income Integer Holdings Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.4 M | 59.3 M | 49.6 M | - | 58 M | 54.5 M | 38.7 M | - | 48.8 M | 41.6 M | 34.2 M | - | 29.3 M | 32.7 M | 22.5 M | - | 33.1 M | 39.4 M | 34.6 M | - | 39.8 M | 9.18 M | 44.1 M | - | 46.5 M | 49.3 M | 39.2 M | - | 41.5 M | 44.4 M | 30 M | - | 35.8 M | 36.1 M | 26.5 M | - | 36.9 M | 29.3 M | 11.1 M | - | 1.2 M | 13 M | 9.39 M | - | 16.2 M | 19.5 M | 22.5 M | - | 17 M | 17.1 M | 14.3 M | - | 2.13 M | 11.1 M | 11.2 M | - | 12.9 M | 18.3 M | 18 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 59.3 M | 1.2 M | 30.1 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.2 | 0.24 % | $ 889 M |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 62.85 | -0.62 % | $ 3.43 B |  Britain |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
-10.7 M | $ 6.01 | -0.99 % | $ 69.2 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.02 | -0.88 % | $ 323 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 86.6 | -0.7 % | $ 111 B | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 31.55 | -0.63 % | $ 1.45 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.63 | - | $ 1.14 B | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.03 | -1.88 % | $ 203 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Myomo
MYO
|
-14.4 M | $ 0.7 | -0.79 % | $ 29.3 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.67 | - | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.2 | -4.34 % | $ 3.43 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-56.7 M | $ 2.39 | -2.05 % | $ 140 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 10.61 | 2.31 % | $ 1.43 B | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 11.76 | -0.93 % | $ 466 M |  Curacao |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 98.85 | -0.35 % | $ 1.26 B | USA |
 |
Outset Medical
OM
|
-66.7 M | $ 3.56 | -1.66 % | $ 54.2 K | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.73 | - | $ 139 M |  France |
 |
Varex Imaging Corporation
VREX
|
-27.8 M | $ 10.66 | -1.48 % | $ 441 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.3 | -1.03 % | $ 382 M | USA |
 |
Penumbra
PEN
|
189 M | $ 334.77 | -0.24 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 51.01 | -2.3 % | $ 1.5 B | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 222.59 | -1.98 % | $ 15.7 B | USA |
 |
Profound Medical Corp.
PROF
|
-30.3 M | $ 5.36 | -0.74 % | $ 180 M | Canada |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.35 | -3.24 % | $ 54.9 M | USA |
 |
Quanterix Corporation
QTRX
|
-126 M | $ 3.87 | -1.78 % | $ 165 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
InspireMD
NSPR
|
-49.6 M | $ 1.75 | 0.87 % | $ 113 M | Israel |